Literature DB >> 23292714

Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10(+) IFN-γ(+)-producing CD4(+) T cells.

Fang Zhou1, Bogoljub Ciric, Guang-Xian Zhang, Abdolmohamad Rostami.   

Abstract

Dendritic cells (DCs) regulate immunity and immune tolerance in vivo. However, the mechanisms of DC-mediated tolerance have not been fully elucidated. Here, we demonstrate that intravenous (i.v.) transfer of bone marrow-derived DCs pulsed with myelin oligodendrocyte glycoprotein (MOG) peptide blocks the development of experimental autoimmune encephalomyelitis in C57BL/6J mice. i.v. transfer of MOG-pulsed DCs leads to the down-regulation of the production of IL-17A and IFN-γ and up-regulation of IL-10 secretion. The development of regulatory T cells (Tregs) is facilitated via up-regulation of FoxP3 expression and production of IL-10. The number of suppressive CD4(+)IL-10(+)IFN-γ(+) T cells is also improved. The expression of OX40, CD154, and CD28 is down-regulated, but the expression of CD152, CD80, PD-1, ICOS, and BTLA is up-regulated on CD4(+) T cells after i.v. transfer of immature DCs. The expression of CCR4, CCR5, and CCR7 on CD4(+) T cells is also improved. Our results suggest that immature DCs may induce tolerance via facilitating the development of CD4(+)FoxP3(+) Tregs and suppressive CD4(+)IL-10(+)IFN-γ(+) T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23292714      PMCID: PMC3628929          DOI: 10.1007/s12026-012-8382-7

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  29 in total

1.  CD4+ T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis.

Authors:  Joseph R Podojil; Adam P Kohm; Stephen D Miller
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

2.  Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance.

Authors:  Ramesh K Selvaraj; Terrence L Geiger
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

3.  CCR7 mediates the migration of Foxp3+ regulatory T cells to the paracortical areas of peripheral lymph nodes through high endothelial venules.

Authors:  Satoshi Ueha; Hiroyuki Yoneyama; Shigeto Hontsu; Makoto Kurachi; Masahiro Kitabatake; Jun Abe; Osamu Yoshie; Shiro Shibayama; Tetsuya Sugiyama; Kouji Matsushima
Journal:  J Leukoc Biol       Date:  2007-08-14       Impact factor: 4.962

Review 4.  The B7/CD28 costimulatory family in autoimmunity.

Authors:  Mary E Keir; Arlene H Sharpe
Journal:  Immunol Rev       Date:  2005-04       Impact factor: 12.988

5.  PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.

Authors:  Laura L Carter; Michael W Leach; Mihai L Azoitei; Junqing Cui; Jeffrey W Pelker; Jason Jussif; Steve Benoit; Gretchen Ireland; Deborah Luxenberg; G Roger Askew; Kim L Milarski; Christopher Groves; Tom Brown; Brenda A Carito; Karen Percival; Beatriz M Carreno; Mary Collins; Suzana Marusic
Journal:  J Neuroimmunol       Date:  2006-12-19       Impact factor: 3.478

6.  CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients.

Authors:  F Gerosa; C Nisii; S Righetti; R Micciolo; M Marchesini; A Cazzadori; G Trinchieri
Journal:  Clin Immunol       Date:  1999-09       Impact factor: 3.969

7.  Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.

Authors:  A D Weinberg; K W Wegmann; C Funatake; R H Whitham
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

8.  BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.

Authors:  Norihiko Watanabe; Maya Gavrieli; John R Sedy; Jianfei Yang; Francesca Fallarino; Susan K Loftin; Michelle A Hurchla; Natalie Zimmerman; Julia Sim; Xingxing Zang; Theresa L Murphy; John H Russell; James P Allison; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2003-06-08       Impact factor: 25.606

9.  Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Martin E Dorf; Engin Ozkaynak; Wayne W Hancock
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

10.  CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells.

Authors:  Martin A Schneider; Josef G Meingassner; Martin Lipp; Henrietta D Moore; Antal Rot
Journal:  J Exp Med       Date:  2007-03-19       Impact factor: 14.307

View more
  16 in total

1.  Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis.

Authors:  F Zhou; B Ciric; G-X Zhang; A Rostami
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

2.  Tolerance of activated pathogenic CD4+ T cells by transcriptional targeting of dendritic cells.

Authors:  B de Andrade Pereira; M Ackermann; S Chaudhary; R Vogel; B Vogt; C Dresch; C Fraefel
Journal:  Gene Ther       Date:  2015-03-05       Impact factor: 5.250

3.  Apoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4⁺ effector memory T cells.

Authors:  Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

4.  Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.

Authors:  Fang Zhou; Elisabetta Lauretti; Antonio di Meco; Bogoljub Ciric; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunobiology       Date:  2013-03-01       Impact factor: 3.144

5.  LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+ regulatory T cell subpopulations mediated by 3G11 and CD127.

Authors:  Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

6.  Protection against Paracoccidioides brasiliensis infection in mice treated with modulated dendritic cells relies on inhibition of interleukin-10 production by CD8+ T cells.

Authors:  Thiago Alves da Costa; Rosária Di Gangi; Paula Martins; Ana Leda Figueiredo Longhini; Fábio Zanucoli; Alexandre Leite Rodrigues de Oliveira; Dagmar Ruth Stach-Machado; Eva Burger; Liana Verinaud; Rodolfo Thomé
Journal:  Immunology       Date:  2015-09-21       Impact factor: 7.397

Review 7.  Melanoma vaccines: mixed past, promising future.

Authors:  Junko Ozao-Choy; Delphine J Lee; Mark B Faries
Journal:  Surg Clin North Am       Date:  2014-08-07       Impact factor: 2.741

8.  Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.

Authors:  Hanbo Hu; Xiaoyan Zhu; Sunil Joshi; Li Lu; Chang-Qing Xia; Jawaharlal M Patel
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 9.  Regulatory dendritic cells for immunotherapy in immunologic diseases.

Authors:  John R Gordon; Yanna Ma; Laura Churchman; Sara A Gordon; Wojciech Dawicki
Journal:  Front Immunol       Date:  2014-01-31       Impact factor: 7.561

10.  Dendritic cell-secreted lipocalin2 induces CD8+ T-cell apoptosis, contributes to T-cell priming and leads to a TH1 phenotype.

Authors:  Melanie Floderer; Michaela Prchal-Murphy; Caterina Vizzardelli
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.